Sense Neuro Diagnostics
Sense Neuro Diagnostics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
About Sense Neuro Diagnostics
Based in the United States, Sense Neuro Diagnostics is a startup founded in 2017. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Sense Neuro Diagnostics develops non-invasive, AI-enabled neurodiagnostic medical devices designed to rapidly detect intracranial bleeding and acute neurological conditions at the point of care. Their technology uses proprietary RF-based sensing hardware integrated with machine learning algorithms to enable real-time brain assessment in emergency departments, ambulances, and military medical units.
Explore Sense Neuro Diagnostics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.